1. Home
  2. HIMX vs SUPN Comparison

HIMX vs SUPN Comparison

Compare HIMX & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Himax Technologies Inc.

HIMX

Himax Technologies Inc.

HOLD

Current Price

$13.75

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$47.04

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIMX
SUPN
Founded
2001
2005
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.8B
IPO Year
2006
2010

Fundamental Metrics

Financial Performance
Metric
HIMX
SUPN
Price
$13.75
$47.04
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$61.60
AVG Volume (30 Days)
1.5M
958.1K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
3.23%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$392,755,000.00
Revenue This Year
$14.94
$22.70
Revenue Next Year
$7.79
$19.14
P/E Ratio
$14.99
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.85
$40.32
52 Week High
$25.09
$59.68

Technical Indicators

Market Signals
Indicator
HIMX
SUPN
Relative Strength Index (RSI) 49.52 50.78
Support Level $12.49 $43.43
Resistance Level $16.07 $47.55
Average True Range (ATR) 0.72 2.49
MACD 0.26 -0.13
Stochastic Oscillator 80.34 41.87

Price Performance

Historical Comparison
HIMX
SUPN

About HIMX Himax Technologies Inc.

Himax Technologies Inc is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The majority of the firm's revenue is derived from the Driver Integrated Circuit segment. It offers display driver ICs and timing controllers used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, virtual reality (VR) devices, and many other consumer electronics devices. It also designs and provides controllers for touch sensor displays, in-cell Touch and Display Driver Integration single-chip solutions, LED driver ICs, power management ICs, and scaler products for monitors and projectors. Geographically, it generates the majority of its revenue from China.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: